Navigation Links
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
Date:5/13/2013

or 510.856.5598.

 ANTHERA PHARMACEUTICALS, INC.(A Development Stage Company)CONDENSED STATEMENTS OF OPERATIONS (in thousands, except share and per share data)(unaudited)Three Months Ended March 31,20132012Operating expenses:Research and development

$

4,929

(1)$

17,738General and administrative1,972

(2)2,322Total operating expenses6,90120,060Loss from operations(6,901)(20,060)Other income (expenses):Other income (expense) - net25(10)Interest expense(704)(843)Total other (expense) - net(679)(853)Net loss attributable to common stockholders

$

(7,580)$

(20,913)Net loss per share attributable to common stockholders:Basic and diluted

 

$

 

(0.06) 

$

 

(0.51)Weighted-average number of shares used to compute net loss per share of common stock—basic and diluted 

124,124,066 

41,000,421(1)

Included in research and development expenses is a one-time charge of stock-based compensation of approximately $799,000 associated with the voluntary surrender of stock options by our employees during the three months ended March 31, 2013.(2)

Included in general and administrative expenses is a one-time charge of stock-based compensation of approximately $661,000 associated with the voluntary surrender of stock options by our employees during the three months ended March 31, 2013. 

 ANTHERA PHARMACEUTICALS, INC.(A Development Stage Company)BALANCE SHEET DATA(in thousands, except share data)(unaudited)March 31, 2013December 31,
2012Cash and cash equivalents

$
50,570$
9,431Short term investments

$
3,824$
5,322Total assets

$
56,452$
26,445Total current liabilities, excluding current portion of notes payable

$
4,706$
9,421Total notes payable

$
8,393$
20,550Deficit accumulated during development
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
2. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
3. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
5. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
6. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
7. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
8. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
9. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
11. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 Nektar Therapeutics ... Inc. today announced positive results from its Phase ... investigational, extended half-life recombinant factor VIII (rFVIII) treatment ... (Recombinant)], which met its primary endpoint in reducing ... compared to the on-demand arm. Top-line ...
(Date:8/21/2014)... -- The spinal column is one of the most delicate ... and from the brain through the column control many key ... ailment here can be life altering, and leave the victim ... their body. Though back injury and disease can have an ... options available to make things better than ever before. ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... 5, 2011 Elekta,s MOSAIQ® Oncology Information System ... No. 1 ranking in the oncology software category from ... Category Leader designation identifies top-rated vendor products in the ... for each market segment. The 2010 ...
... (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, ... at the J.P. Morgan 29th Annual Healthcare Conference in San ...   Interested parties may access a live audio ... the BioMarin website, www.BMRN.com .  A replay of the ...
Cached Medicine Technology:Elekta's MOSAIQ Oncology Information System Named Category Leader in '2010 Top 20 Best in KLAS Awards' Report 2Elekta's MOSAIQ Oncology Information System Named Category Leader in '2010 Top 20 Best in KLAS Awards' Report 3BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference 2
(Date:8/22/2014)... 22, 2014 For patients who need surgery for ... procedure is the least often used, reports a study ... , official journal of the Congress of Neurological ... Williams & Wilkins , a part of Wolters ... good pain relief at much lower cost than other ...
(Date:8/22/2014)... Ticket Down is a reliable source ... Orleans, Albuquerque and Rapid City. For fans looking to speak ... Caputo, allows just that. Caputo was born and raised in ... close knit family who began to see spirits when she ... she had a chance to do what most people wished ...
(Date:8/22/2014)... Pirate Jonny's Caribbean BBQ Rubs, ... new recipe cards, fun t-shirts, and caps for consumers ... Clearwater, Florida, Pirate Jonny, aka, Jonathan Toner, founder, decided ... to three recipes featuring different flavors of the Caribbean, ... website. The recipe cards will feature "easy to ...
(Date:8/22/2014)... According to the new research ... Global Trends & Forecast to 2019" defines and ... forecast of the market value. The isocyanate material ... 2019, at a significant CAGR from 2014 to ... 44 figures spread through 286 pages and in-depth ...
(Date:8/22/2014)... Society for Medical Oncology (ESMO), the leading pan-European ... names of three outstanding individuals receiving the Society,s ... to Carsten Bokemeyer, Heikki Joensuu and Peter Boyle ... 26-30 September, Madrid, Spain. , Carsten Bokemeyer will ... accelerate the transition of cancer discovery into real ...
Breaking Medicine News(10 mins):Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3
... Sharing a favorite ritual might ease a friend or family member,s ... member or friend is in the hospital over the holidays, you ... from home. , "Being in the hospital, away from family ... people," Denice Foose, a chaplain at The Methodist Hospital in Houston, ...
... be possible to grow human blood platelets in the ... The Ohio State University Medical Center. , The findings, ... journal Experimental Hematology , might one day enable ... that can ease the chronically tight supply of these ...
... J Lounge in downtown Los Angeles, on Friday, December 26th starting at ... Diamond Foundation, which was founded to assist people who need access to ... ... Boxer Manny Pacquiao, fresh off his victory against Oscar Dela Hoya in ...
... ingredients not listed on label , , MONDAY, Dec. 22 ... warned consumers Monday to avoid more than two dozen ... ingredients that could pose serious health risks. , The ... the Internet and some claim to contain only "natural" ...
... the way people around the world communicate and do business. ... to do the same thing for medicine. ... Aydogan Ozcan, a prototype cell phone has been constructed that ... patients, as well as testing water quality in undeveloped areas ...
... the animals from smoke,s harmful effects, researchers say , , ... mice, scientists have shown that a new drug may ... cigarettes. , The finding holds out hope for patients ... progressive lung disease involving both emphysema and chronic obstructive ...
Cached Medicine News:Health News:Take the Holiday to the Hospital 2Health News:Bioreactors might solve blood-platelet supply problems 2Health News:Pacquiao Hosts Post-Christmas/Post-Birthday Victory Celebration 2Health News:FDA Warns About Weight Loss Products 2Health News:FDA Warns About Weight Loss Products 3Health News:Cell phones using lens-free imaging promise to improve health monitoring 2Health News:Drug Shields Mice From Emphysema 2
The portable, cost-effective system designed for fast studies and bedside reporting. The size, features and cost make this a perfect unit for a new practice, or as a second or third unit for larger h...
BB Watchmaker Forceps, Pakistan, 4.5" fine point....
The vertebral body replacement (VBR) is used for the anterior thoracic and lumbar spine. It is intended for use in the thoracic and lumbar spine to replace a collapsed, damaged, or unstable vertebral...
Vertigraft femoral shaft an large femoral cross-section designed primarily for use in lumbar corpectomy procedures. Freeze dried preservation....
Medicine Products: